Four Innovative Canadian Medtech Startups to Watch at MedCity INVEST
The group of four healthcare startups spans women's health, orthopedics, remote patient monitoring for Parkinson's disease, AI, and 3D printing. David Kereiakes, Managing Partner, Windham Venture Partners will moderate the session.
Abbott Earns FDA Approval For Dissolving Stent That Unclogs Arteries Below The Knee
Abbott earned FDA approval for its dissolving stent designed to unclog arteries below the knee. This marks the first time the FDA has approved a stent or drug-coated balloon to help arteries stay open below the knee.
Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency
The FDA approved X4 Pharmaceuticals drug Xolremdi for treating WHIM syndrome. The molecule, which addresses the underlying cause of this rare immunodeficiency, was licensed from Sanofi’s Genzyme subsidiary.
Pivot Podcast: A Conversation with Capital Rx CEO A.J. Loiacono
Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of pharmacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx.
Navigating Healthcare’s New Era of Algorithmic Transparency
What EHR/EMR vendors need to know to comply with ONC’s HTI-1 final rule